![Scott Sudduth](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Scott Sudduth
Technik-/Wissenschafts-/F&E-Leiter bei
COLLEGIUM PHARMACEUTICAL, INC.
Profil
Scott Sudduth is currently Executive VP & Head-Technical Operations at Collegium Pharmaceutical, Inc. since 2021.
Former positions include Vice President at Genzyme Corp.
and Head-Supply Chain at Moderna, Inc. Education includes an undergraduate degree from Clarkson University.
Aktive Positionen von Scott Sudduth
| Unternehmen | Position | Beginn |
|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2021 |
Ehemalige bekannte Positionen von Scott Sudduth
| Unternehmen | Position | Ende |
|---|---|---|
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | - |
| MODERNA, INC. | Corporate Officer/Principal | - |
Ausbildung von Scott Sudduth
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
17
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Collegium Pharmaceutical, Inc.
 Collegium Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Clarkson University
 Clarkson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Moderna, Inc.
 Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
